2023
Human Papillomavirus Vaccination Status and Correlates Among Mid-Adult Women: Connecticut, USA, 2016–2019
Sheth S, Johnson N, Sullivan E, Torres A, Oliveira C, Niccolai L. Human Papillomavirus Vaccination Status and Correlates Among Mid-Adult Women: Connecticut, USA, 2016–2019. Journal Of Women's Health 2023, 33: 28-32. PMID: 37943625, PMCID: PMC10794823, DOI: 10.1089/jwh.2022.0456.Peer-Reviewed Original ResearchConceptsMid-adult womenVaccination statusHPV vaccinationHPV vaccineHuman Papillomavirus Vaccination StatusHPV vaccination statusHuman papillomavirus vaccinationAge 26 yearsHealth care providersCross-sectional surveyPapillomavirus vaccinationUnvaccinated womenVaccinated womenVaccine informationCare providersVaccinationAdult womenVaccineWomenBehavioral correlatesCorrelatesStatusPotential benefitsYearsParticipants
2022
Pediatric COVID-19 Health Disparities and Vaccine Equity
Oliveira CR, Feemster KA, Ulloa ER. Pediatric COVID-19 Health Disparities and Vaccine Equity. Journal Of The Pediatric Infectious Diseases Society 2022, 11: s141-s147. PMID: 36124679, PMCID: PMC9494479, DOI: 10.1093/jpids/piac091.Commentaries, Editorials and LettersConceptsVaccine equityHealth disparitiesLong-term complicationsCOVID-19 health disparitiesCOVID-19 infectionCOVID-19 vaccineMild illnessPediatric populationVaccine uptakePoor outcomeSevere diseaseVaccine inequityMost childrenEthnic minority groupsChildrenSame childrenInfectionLow-income homesDisparitiesComplicationsGroupVaccineIllnessDiseaseSeverity
2021
Patterns of recommended vaccine receipt among women ages 24–45 years: a cross-sectional analysis
Ellingson MK, Oliveira CR, Sheth SS, Sullivan EL, Torres A, Shapiro ED, Niccolai LM. Patterns of recommended vaccine receipt among women ages 24–45 years: a cross-sectional analysis. BMC Public Health 2021, 21: 1283. PMID: 34193100, PMCID: PMC8247221, DOI: 10.1186/s12889-021-11340-4.Peer-Reviewed Original ResearchConceptsMid-adult womenVaccine receiptCross-sectional analysisHPV vaccineOngoing case-control studyReceipt of influenzaHealth care visitsCase-control studyWomen ages 24Quarter of adultsLogistic regression analysisCare visitsIndividual vaccinesHealthcare utilizationMultiple vaccinesVaccineAge 24White womenWomenDemographic characteristicsRegression analysisLower ratesInfluenzaReceiptPast yearClinical Effectiveness of Lyme Vaccine: A Matched Case–Control Study
Oliveira CR, Massad C, Shapiro ED, Vazquez M. Clinical Effectiveness of Lyme Vaccine: A Matched Case–Control Study. Open Forum Infectious Diseases 2021, 8: ofab142. PMID: 34409119, PMCID: PMC8364756, DOI: 10.1093/ofid/ofab142.Peer-Reviewed Original ResearchInpatient Immunization With HPV Vaccine: A Qualitative Study With Postpartum Women
Avni-Singer L, Oliveira CR, Torres A, Shapiro ED, Niccolai LM, Sheth SS. Inpatient Immunization With HPV Vaccine: A Qualitative Study With Postpartum Women. Women's Health Issues 2021, 31: 384-391. PMID: 33715924, PMCID: PMC8260440, DOI: 10.1016/j.whi.2021.02.002.Peer-Reviewed Original ResearchConceptsHPV vaccinePostpartum womenPatient-centered approachHPV immunization programHuman papillomavirus vaccineRates of immunizationIterative thematic approachYoung adult femalesInpatient immunizationHospital dischargePapillomavirus vaccinePostpartum patientsMedian ageImmunization programsPatient's perspectiveProgram implementationVaccine hesitancyImmunizationVaccineWomenQualitative studyThematic approachPatientsHospitalAdult femalesMonitoring HPV vaccine impact on cervical disease: Status and future directions for the era of cervical cancer elimination
Oliveira CR, Niccolai LM. Monitoring HPV vaccine impact on cervical disease: Status and future directions for the era of cervical cancer elimination. Preventive Medicine 2021, 144: 106363. PMID: 33678234, PMCID: PMC8582276, DOI: 10.1016/j.ypmed.2020.106363.Commentaries, Editorials and LettersConceptsCervical cancer eliminationCancer eliminationHPV vaccineCervical cancerImportant public health goalHPV vaccine impactPost-licensure monitoringPopulation-level burdenProlonged latency periodImportant public health activityPublic health activitiesPublic health goalsHPV vaccinationCervical infectionCervical diseaseVaccine impactInvasive diseaseLatency periodConvincing benefitHealth goalsHealth activitiesVaccineDiseaseUrgent research priorityCancer
2019
Human papillomavirus vaccination and anogenital warts
Yakely AE, Avni-Singer L, Oliveira CR, Niccolai LM. Human papillomavirus vaccination and anogenital warts. Sexually Transmitted Diseases 2019, Publish Ahead of Print: &na;. PMID: 30461595, PMCID: PMC6640846, DOI: 10.1097/olq.0000000000000948.Peer-Reviewed Original ResearchConceptsAnogenital wartsAge 25 yearsHPV vaccineEffectiveness studiesHPV vaccine impactHuman papillomavirus vaccinationPre-vaccine eraMale vaccinationPapillomavirus vaccinationVaccination historyVaccine impactVaccine introductionFemale vaccinationEmbase databasesVaccination programEligible studiesExclusion criteriaLower riskVaccineVaccinationWartsPrevention potentialReal-world benefitsFemalesUnited States
2018
Impact of a clinical interventions bundle on uptake of HPV vaccine at an OB/GYN clinic
Deshmukh U, Oliveira CR, Griggs S, Coleman E, Avni-Singer L, Pathy S, Shapiro ED, Sheth SS. Impact of a clinical interventions bundle on uptake of HPV vaccine at an OB/GYN clinic. Vaccine 2018, 36: 3599-3605. PMID: 29759380, PMCID: PMC6314176, DOI: 10.1016/j.vaccine.2018.05.039.Peer-Reviewed Original ResearchConceptsIntervention bundleOB/GYN clinicPrevalence of womenUninsured womenVaccine uptakeAttributable reductionsMissed opportunityHPV vaccine seriesVaccine-eligible visitsVaccine-eligible womenHPV vaccine uptakeMonthly rateYoung adult womenLast study monthInterrupted time series modelHPV vaccineVaccine seriesMedical recordsHispanic womenAdult womenWhite womenStudy periodYoung adultsVaccineWomen